Long-Term Safety of Drug Eluting Stents in the "Real World" (FReIburger STent Registry) (FRIST)

University Hospital Freiburg

Status: Unknown

Conditions: Stent Thrombosis

Treatments: Procedure: transluminal percutaneous coronary intervention; Device: Drug-Eluting and Bare-Metal stents

Study type: Observational

Funder types: Other

Identifiers

NCT00905008

FRIST_GH0102

Details and patient eligibility

About

The FReIburger STent Registry (FRIST) is designed to determine the long term safety and efficacy of Drug Eluting Stents (DES) in a "real-world" patient population requiring stent implantation.

FRIST included patients treated with DES and bare-metal stents (BMS) in the University Hospital of Freiburg, Germany, according to a non-restrictive inclusion criterion, in which virtually all consecutive patient subsets were considered eligible.

Enrollment: 1,502 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Consecutive patients undergoing percutaneous coronary intervention

Exclusion criteria

• Patient refusal or inability to provide written informed consent

Trial design

1,502 participants in 2 patient groups

DES

Description:

Patients underwent percutaneous coronary intervention and received at least one drug-eluting stent during their index hospitalisation.

Treatment:

Procedure: transluminal percutaneous coronary intervention

Device: Drug-Eluting and Bare-Metal stents

BMS

Description:

Patients underwent percutaneous coronary intervention and received at least one uncoated stent during their index hospitalisation.

Treatment:

Procedure: transluminal percutaneous coronary intervention

Device: Drug-Eluting and Bare-Metal stents